Journal
CHEMICAL SOCIETY REVIEWS
Volume 39, Issue 11, Pages 4326-4354Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b915139g
Keywords
-
Categories
Funding
- NIH [R01CA131797, R01CA140295]
- NSF
- Department of Bioengineering at the University of Washington
- UW Center for Nanotechnology
- Mary Gates Endowment for Students for Research Scholarship
- Amgen
- NATIONAL CANCER INSTITUTE [R01CA131797, R01CA140295] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The emerging field of bionanotechnology aims at revolutionizing biomedical research and clinical practice via introduction of nanoparticle-based tools, expanding capabilities of existing investigative, diagnostic, and therapeutic techniques as well as creating novel instruments and approaches for addressing challenges faced by medicine. Quantum dots (QDs), semiconductor nanoparticles with unique photo-physical properties, have become one of the dominant classes of imaging probes as well as universal platforms for engineering of multifunctional nanodevices. Possessing versatile surface chemistry and superior optical features, QDs have found initial use in a variety of in vitro and in vivo applications. However, careful engineering of QD probes guided by application-specific design criteria is becoming increasingly important for successful transition of this technology from proof-of-concept studies towards real-life clinical applications. This review outlines the major design principles and criteria, from general ones to application-specific, governing the engineering of novel QD probes satisfying the increasing demands and requirements of nanomedicine and discusses the future directions of QD-focused bionanotechnology research (critical review, 201 references).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available